Table 2.
Treatment | SW480 | SW620 | ||||
---|---|---|---|---|---|---|
Live (%) | Dead (%) | Apoptotic (%) | Live (%) | Dead (%) | Apoptotic (%) | |
NTC | 84.33 ± 0.33 | 10.33 ± 0.33 | 5.33 ± 0.33 | 84.00 ± 2.00 | 12.33 ± 1.76 | 3.67 ± 0.67 |
Mock | 87.00 ± 1.53 | 11.00 ± 0.00 | 2.00 ± 1.53 | 81.67 ± 0.67 | 16.00 ± 0.58 | 2.00 ± 0.00 |
miR-23a mimic | 85.33 ± 1.20 | 13.00 ± 1.00 | 1.33 ± 0.88 | 85.00 ± 1.15 | 10.00 ± 0.00 | 5.00 ± 1.15 |
Mimic NC | 83.67 ± 0.88 | 13.00 ± 0.58 | 2.67 ± 0.33 | 78.33 ± 0.88 | 14.00 ± 0.58 | 7.33 ± 0.88 |
miR-23a inhibitor | 65.67 ±1.45 | 9.00 ± 1.00 | 25.33 ± 1.86 | 68.00 ± 1.73 | 13.33 ± 0.67 | 18.33 ± 2.60 |
Inhibitor NC | 85.00 ± 1.53 | 11.67 ± 0.67 | 3.67 ± 1.20 | 78.67 ± 1.20 | 15.00 ± 0.58 | 6.00 ± 1.15 |
Doxorubicin | 54.33 ± 4.67 | 23.67 ± 0.88 | 22.33 ± 5.33 | 48.33 ± 4.84 | 27.00 ± 2.08 | 24.33 ± 2.91 |